[Market Focus] Dongkook Lifescience Surges on 1-for-1 Bonus Issue Decision

Dongkook Lifescience is showing strong performance. This appears to be influenced by the announcement of a 1-for-1 bonus issue.

As of 1:59 p.m. on July 24, Dongkook Lifescience was trading at 9,770 won, up 730 won (8.08%) from the previous trading day.

On this day, Dongkook Lifescience announced that its board of directors had resolved to carry out a 100% bonus issue, allocating one new share for every existing share. As a result, the total number of common shares issued will increase from 15,990,000 to 31,980,000.

This bonus issue is being implemented to strengthen shareholder return policies and to promote trading activity by increasing the number of shares in circulation, based on the company's solid performance and financial stability since its listing on KOSDAQ. The record date for the allocation of new shares is August 8, 2025, and the new shares are scheduled to be listed on August 29. After the bonus issue is completed, the company's capital will increase from approximately 8 billion won to 16 billion won.

A company representative stated, "We have focused on maximizing shareholder value and expanding our investor base by increasing liquidity through this capital increase," adding, "This is an extension of our shareholder-friendly management policy since our KOSDAQ listing."